Moreover, folate supplementation improves autophagic impairment and alleviates lipid accumulation caused by the inhibited activity of cathepsin L. These findings offer a promising approach for treating hepatopathology related to lysosomal/autophagic dysfunction, including non-folate deficiency-induced fatty liver. The gene discussed is CTSL; the disease is fatty liver disease.